The Expanding Role of Tandem Mass Spectrometry in Optimizing Diagnosis and Treatment of Thyroid Disease

Advances in Clinical Chemistry

Volumn 61, Issue , 2013, Pages 127-152

  Van Deventer, Hendrick E ^a   Soldin, Steven J ^b  

^a LANCET LABORATORIES   (South Africa)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Deiodinase; Equilibrium dialysis; Inverse log linear relationship; Pregnancy; Tandem mass spectrometry; Thyroid; Thyroid hormones; Thyroid stimulating hormone (TSH); Ultrafiltration

Indexed keywords

EID: 84878666883     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407680-8.00005-1     Document Type: Chapter

References (116)

1. Braverman L.E., Ingbar S.H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J. Clin. Invest. 1970, 49:855-864.
2. Nicoloff J.T., Lum S.M., Spencer C.A., Morris R. Peripheral autoregulation of thyroxine to triiodothyronine conversion in man. Horm. Metab. Res. Suppl. 1984, 14:74-79.
3. Kohrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell. Endocrinol. 1999, 151:103-119.
4. Kohrle J. The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev. Endocr. Metab. Disord. 2000, 1:49-58.
5. Schussler G.C. The thyroxine-binding proteins. Thyroid 2000, 10:141-149.
6. Mendel C.M., Weisiger R.A. Thyroxine uptake by perfused rat liver. No evidence for facilitation by five different thyroxine-binding proteins. J. Clin. Invest. 1990, 86:1840-1847.
7. Midgley J.E. The free thyroid hormone hypothesis and measurement of free hormones. Clin. Chem. 1993, 39:1342-1344.
8. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 1989, 10:232-274.
9. Ellis S.M., Ekins R.P. Proceedings: the radioimmunoassay of free (diffusible) T3 and T4 concentrations in serum. J. Endocrinol. 1973, 59:43.
10. Weeke J., Orskov H. Ultrasensitive radioimmunoassay for direct determination of free triiodothyronine concentration in serum. Scand. J. Clin. Lab. Invest. 1975, 35:237-244.
11. Stockigt J.R. Free thyroid hormone measurement. A critical appraisal. Endocrinol. Metab. Clin. North Am. 2001, 30:265-289.
12. Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126.
13. Nelson J.C., Wang R., Asher D.T., Wilcox R.B. The nature of analogue-based free thyroxine estimates. Thyroid 2004, 14:1030-1036.
14. Midgley J.E., Christofides N.D. Point: legitimate and illegitimate tests of free-analyte assay function. Clin. Chem. 2009, 55:439-441.
15. Wilcox R.B., Nelson J.C. Counterpoint: legitimate and illegitimate tests of free-analyte assay function: we need to identify the factors that influence free-analyte assay results. Clin. Chem. 2009, 55:442-444.
16. Fritz K.S., Wilcox R.B., Nelson J.C. A direct free thyroxine (t4) immunoassay with the characteristics of a total t4 immunoassay. Clin. Chem. 2007, 53:911-915.
17. d'Herbomez M., Forzy G., Gasser F., Massart C., Beaudonnet A., Sapin R. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin. Chem. Lab. Med. 2003, 41:942-947.
18. Ekins R. Validity of analog free thyroxin immunoassays. Clin. Chem. 1987, 33:2137-2144.
19. Midgley J.E., Moon C.R., Wilkins T.A. Validity of analog free thyroxin immunoassays. Part II. Clin. Chem. 1987, 33:2145-2152.
20. Bayer M.F. Free thyroxine results are affected by albumin concentration and nonthyroidal illness. Clin. Chim. Acta 1983, 130:391-396.
21. Csako G., Zweig M.H., Glickman J., Ruddel M., Kestner J. Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. II. Effect of prealbumin, albumin, and thyroxin-binding globulin. Clin. Chem. 1989, 35:1655-1662.
22. Soldin O.P., Soldin S.J. Thyroid hormone testing by tandem mass spectrometry. Clin. Biochem. 2011, 44:89-94.
23. Kahric-Janicic N., Soldin S.J., Soldin O.P., West T., Gu J., Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 2007, 17:303-311.
24. van Deventer H.E., Mendu D.R., Remaley A.T., Soldin S.J. Inverse log-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry. Clin. Chem. 2011, 57:122-127.
25. Soldin S.J., Soukhova N., Janicic N., Jonklaas J., Soldin O.P. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin. Chim. Acta 2005, 358:113-118.
26. Soldin S.J., Cheng L.L., Lam L.Y., Werner A., Le A.D., Soldin O.P. Comparison of FT4 with Log TSH on the Abbott Architect Ci8200: pediatric reference intervals for free thyroxine and thyroid-stimulating hormone. Clin. Chim. Acta 2010, 411:250-252.
27. Jonklaas J., Soldin S.J. Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships. Thyroid 2008, 18:1303-1311.
28. Clark P.M., Holder R.L., Haque S.M., Hobbs F.D., Roberts L.M., Franklyn J.A. The relationship between serum TSH and free T4 in older people. J. Clin. Pathol. 2012, 65:463-465.
29. Serdar M.A., Ozgurtas T., Ispir E., Kenar L., Senes M., Yücel D., et al. Comparison of relationships between FT4 and Log TSH in Access DXI 800 Unicel, Modular E170 and Advia Centaur XP Analyzer. Clin. Chem. Lab. Med. 2012, 50:1849-1852.
30. Larsen P.R. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med. 1982, 306:23-32.
31. Spencer C.A., LoPresti J.S., Patel A., Guttler R.B., Eigen A., Shen D., et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J. Clin. Endocrinol. Metab. 1990, 70:453-460.
32. Jonklaas J., Kahric-Janicic N., Soldin O.P., Soldin S.J. Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin. Chem. 2009, 55:1380-1388.
33. Hoermann R., Eckl W., Hoermann C., Larisch R. Complex relationship between free thyroxine and Tsh in the regulation of thyroid function. Eur. J. Endocrinol. 2010, 162:1123-1129.
34. Hansen P.S., Brix T.H., Sorensen T.I., Kyvik K.O., Hegedus L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of Healthy Danish Twins. J. Clin. Endocrinol. Metab. 2004, 89:1181-1187.
35. Nelson J.C., Wilcox R.B. Analytical performance of free and total thyroxine assays. Clin. Chem. 1996, 42:146-154.
36. Loh T.P., Kao S.L., Halsall D.J., Toh S.A., Chan E., Ho S.C., et al. Macro-thyrotropin: a case report and review of literature. J. Clin. Endocrinol. Metab. 2012, 97:1823-1828.
37. Soukhova N., Soldin O.P., Soldin S.J. Isotope dilution tandem mass spectrometric method for T4/T3. Clin. Chim. Acta 2004, 343:185-190.
38. Jonklaas J., Davidson B., Bhagat S., Soldin S.J. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008, 299:769-777.
39. Nguyen L.T., Gu J., Soldin O.P., Soldin S.J. Development and validation of an isotope dilution tandem mass spectrometry method for the simultaneous quantification of 3 iodothyronamine, thyroxine, triiodothyronine, reverse T3 and 3,3l-diiodo-L-thyroninein human serum. Clin. Chem. 2011, 57:A82.
40. Sheehan C.P., Christofides N.D., Sheehan C.P., Christofides N.D. One-step, labeled-antibody assay for measuring free thyroxin. II. Performance in a multicenter trial. Clin. Chem. 1992, 38:19-25.
41. Csako G., Zweig M.H., Benson C., Ruddel M. On the albumin-dependence of measurements of free thyroxin. II. Patients with non-thyroidal illness. Clin. Chem. 1987, 33:87-92.
42. Midgley J.E. Direct and indirect free thyroxine assay methods: theory and practice. Clin. Chem. 2001, 47:1353-1363.
43. Sapin R., d'Herbomez M. Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities. Clin. Chem. 2003, 49:1531-1535.
44. Wang R., Nelson J.C., Weiss R.M., Wilcox R.B. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 2000, 10:31-39.
45. Christofides N.D., Wilkinson E., Stoddart M., Ray D.C., Beckett G.J. Assessment of serum thyroxine binding capacity-dependent biases in free thyroxine assays. Clin. Chem. 1999, 45:520-525.
46. Ekins R. Effect of thyroid hormone-binding proteins and fatty acids on modified analog assays of FT4 and FT3 in serum. Clin. Chem. 1989, 35:708-710.
47. Christofides N.D., Wilkinson E., Stoddart M., Ray D.C., Beckett G.J. Serum thyroxine binding capacity-dependent bias in an automated free thyroxine assay. J. Immunoassay 1999, 20:201-221.
48. Klein R.Z., Haddow J.E., Faix J.D., Brown R.S., Hermos R.J., Pulkkinen A., Mitchell M.L. Prevalence of thyroid deficiency in pregnant women. Clin. Endocrinol. (Oxf) 1991, 35:41-46.
49. Vaidya B., Anthony S., Bilous M., Shields B., Drury J., Hutchison S., Bilous R. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?. J. Clin. Endocrinol. Metab. 2007, 92:203-207.
50. Utiger R.D. Maternal hypothyroidism and fetal development. N. Engl. J. Med. 1999, 341:601-602.
51. de Escobar G.M., Obregon M.J., del Rey F.E. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract. Res. Clin. Endocrinol. Metab. 2004, 18:225-248.
52. Lazarus J.H., Premawardhana L.D. Screening for thyroid disease in pregnancy. J. Clin. Pathol. 2005, 58:449-452.
53. Pop V.J., Kuijpens J.L., van Baar A.L., Verkerk G., van Son M.M., de Vijlder J.J., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. (Oxf) 1999, 50:149-155.
54. Haddow J.E., Palomaki G.E., Allan W.C., Williams J.R., Knight G.J., Gagnon J., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 1999, 341:549-555.
55. Pop V.J., Brouwers E.P., Vader H.L., Vulsma T., van Baar A.L., de Vijlder J.J. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin. Endocrinol. (Oxf) 2003, 59:282-288.
56. Smit B.J., Kok J.H., Vulsma T., Briet J.M., Boer K., Wiersinga W.M. Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr. 2000, 89:291-295.
57. Li Y., Shan Z., Teng W., Yu X., Li Y., Fan C., et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin. Endocrinol. (Oxf) 2010, 72:825-829.
58. Casey B.M., Dashe J.S., Wells C.E., McIntire D.D., Byrd W., Leveno K.J., Cunningham F.G. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 2005, 105:239-245.
59. Leung A.S., Millar L.K., Koonings P.P., Montoro M., Mestman J.H. Perinatal outcome in hypothyroid pregnancies. Obstet. Gynecol. 1993, 81:349-353.
60. Lee R.H., Spencer C.A., Mestman J.H., Miller E.A., Petrovic I., Braverman L.E., Goodwin T.M. Free T4 immunoassays are flawed during pregnancy. Am. J. Obstet. Gynecol. 2009, 200:260-261.
61. Ain K.B., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J. Clin. Endocrinol. Metab. 1987, 65:689-696.
62. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr. Rev. 1997, 18:404-433.
63. Nissim M., Giorda G., Ballabio M., D'Alberton A., Bochicchio D., Orefice R., Faglia G. Maternal thyroid function in early and late pregnancy. Horm. Res. 1991, 36:196-202.
64. Hershman J.M. Role of human chorionic gonadotropin as a thyroid stimulator. J. Clin. Endocrinol. Metab. 1992, 74:258-259.
65. Glinoer D. Regulation of thyroid function in pregnancy: maternal and neonatal repercussions. Adv. Exp. Med. Biol. 1991, 299:197-201.
66. Weeke J., Dybkjaer L., Granlie K., Eskjaer Jensen S., Kjaerulff E., Laurberg P., Magnusson B. A longitudinal study of serum TSH, and Total and free iodothyronines during normal pregnancy. Acta Endocrinol. (Copenh.) 1982, 101:531-537.
67. Roti E., Gardini E., Minelli R., Bianconi L., Flisi M. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J. Endocrinol. Invest. 1991, 14:1-9.
68. Ball R., Freedman D.B., Holmes J.C., Midgley J.E., Sheehan C.P. Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact, not technical artefact. Clin. Chem. 1989, 35:1891-1896.
69. Sapin R., D'Herbomez M., Schlienger J.L. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin. Lab. 2004, 50:581-584.
70. Stagnaro-Green A., Abalovich M., Alexander E., Azizi F., Mestman J., Negro R., et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21:1081-1125.
71. Huang S.A., Dorfman D.M., Genest D.R., Salvatore D., Larsen P.R. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J. Clin. Endocrinol. Metab. 2003, 88:1384-1388.
72. Soldin O.P., Hilakivi-Clarke L., Weiderpass E., Soldin S.J. Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin. Chim. Acta 2004, 349:181-189.
73. Soldin O.P., Tractenberg R.E., Soldin S.J. Differences between measurements of T4 and T3 in pregnant and nonpregnant women using isotope dilution tandem mass spectrometry and immunoassays: are there clinical implications?. Clin. Chim. Acta 2004, 347:61-69.
74. Lim V.S. Thyroid function in patients with chronic renal failure. Am. J. Kidney Dis. 2001, 38:S80-S84.
75. Iitaka M., Kawasaki S., Sakurai S., Hara Y., Kuriyama R., Yamanaka K., et al. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure. Clin. Endocrinol. (Oxf) 1998, 48:739-746.
76. Nishikawa M., Ogawa Y., Yoshikawa N., Yoshimura M., Toyoda N., Shouzu A., Inada M. Plasma Free Thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement. Endocr. J. 1996, 43:487-493.
77. Bianco A.C., Kim B.W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 2006, 116:2571-2579.
78. Kaptein E.M., MacIntyre S.S., Weiner J.M., Spencer C.A., Nicoloff J.T. Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. J. Clin. Endocrinol. Metab. 1981, 52:1073-1077.
79. Chopra I.J., Teco G.N., Nguyen A.H., Solomon D.H. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J. Clin. Endocrinol. Metab. 1979, 49:63-69.
80. Chopra I.J., Huang T.S., Beredo A., Solomon D.H., Chua Teco G.N. Serum thyroid hormone binding inhibitor in nonthyroidal illnesses. Metabolism 1986, 35:152-159.
81. Oppenheimer J.H., Schwartz H.L., Mariash C.N., Kaiser F.E. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J. Clin. Endocrinol. Metab. 1982, 54:757-766.
82. Lim C.F., Bai Y., Topliss D.J., Barlow J.W., Stockigt J.R. Drug and fatty acid effects on serum thyroid hormone binding. J. Clin. Endocrinol. Metab. 1988, 67:682-688.
83. Surks M.I., DeFesi C.R. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 1996, 275:1495-1498.
84. Surks M.I., Sievert R. Drugs and thyroid function. N. Engl. J. Med. 1995, 333:1688-1694.
85. Ross H.A., de Rijke Y.B., Sweep F.C. Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia. Clin. Chem. 2011, 57:524-525.
86. Cartwright D., O'Shea P., Rajanayagam O., Agostini M., Barker P., Moran C., et al. Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. Clin. Chem. 2009, 55:1044-1046.
87. Petersen C.E., Scottolini A.G., Cody L.R., Mandel M., Reimer N., Bhagavan N.V. A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia. J. Med. Genet. 1994, 31:355-359.
88. Frost S.J., Hine K.R., Firth G.B., Wheatley T. Falsely lowered FT4 and raised TSH concentrations in a patient with hyperthyroidism and human anti-mouse monoclonal antibodies. Ann. Clin. Biochem. 1998, 35(Pt 2):317-320.
89. Despres N., Grant A.M. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin. Chem. 1998, 44:440-454.
90. Sakata S., Nakamura S., Miura K. Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. Ann. Intern. Med. 1985, 103:579-589.
91. Li Calzi L., Benvenga S., Battiato S., Santini F., Trimarchi F. Autoantibodies to thyroxin and triiodothyronine in the immunoglobulin G fraction of serum. Clin. Chem. 1988, 34:2561-2562.
92. Norden A.G., Jackson R.A., Norden L.E., Griffin A.J., Barnes M.A., Little J.A. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin. Chem. 1997, 43:957-962.
93. Holm S.S., Hansen S.H., Faber J., Staun-Olsen P. Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine. Clin. Biochem. 2004, 37:85-93.
94. Ekins R. Analytic measurements of free thyroxine. Clin. Lab. Med. 1993, 13:599-630.
95. Ekins R. Measurement of free hormones in blood. Endocr. Rev. 1990, 11:5-46.
96. Van Uytfanghe K., Stockl D., Ross H.A., Thienpont L.M. Use of frozen sera for FT4 standardization: investigation by equilibrium dialysis combined with isotope dilution-mass spectrometry and immunoassay. Clin. Chem. 2006, 52:1817-1821.
97. Yue B., Rockwood A.L., Sandrock T., La'ulu S.L., Kushnir M.M., Meikle A.W. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction-liquid chromatography/tandem mass spectrometry. Clin. Chem. 2008, 54:642-651.
98. Holm S.S., Andreasen L., Hansen S.H., Faber J., Staun-Olsen P. Influence of adsorption and deproteination on potential free thyroxine reference methods. Clin. Chem. 2002, 48:108-114.
99. Nelson J.C., Tomei R.T. Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin. Chem. 1988, 34:1737-1744.
100. van der Sluijs V.G., Vermes I., Bonte H.A., Hoorn R.K. Temperature effects on free-thyroxine measurements: analytical and clinical consequences. Clin. Chem. 1992, 38:1327-1331.
101. Olsen T. Free T4, free T3 and free reverse T3 in dialysates of serum. The influence of electrolytes and Ph with special reference to the physiological range. Scand. J. Clin. Lab. Invest. 1979, 39:53-59.
102. Christensen L.K. Some factors influencing the binding of L-thyroxine by proteins. Acta Endocrinol. (Copenh.) 1961, 36:230-236.
103. Nelson J.C., Weiss R.M. The effect of serum dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness. J. Clin. Endocrinol. Metab. 1985, 61:239-246.
104. Wong T.K., Pekary A.E., Hoo G.S., Bradley M.E., Hershman J.M. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin. Chem. 1992, 38:720-724.
105. Gu J., Soldin O.P., Soldin S.J. Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin. Biochem. 2007, 40:1386-1391.
106. Tikanoja S. Ultrafiltration devices tested for use in a free thyroxine assay validated by comparison with equilibrium dialysis. Scand. J. Clin. Lab. Invest. 1990, 50:663-669.
107. Tikanoja S.H., Liewendahl B.K. New ultrafiltration method for free thyroxin compared with equilibrium dialysis in patients with thyroid dysfunction and nonthyroidal illness. Clin. Chem. 1990, 36:800-804.
108. Soldin O.P., Jang M., Guo T., Soldin S.J. Pediatric reference intervals for free thyroxine and free triiodothyronine. Thyroid 2009, 19:699-702.
109. Thienpont L.M., Van Uytfanghe K., Beastall G., Faix J.D., Ieiri T., Miller W.G., et al. Report of the IFCC working group for standardization of thyroid function tests; Part 2: free thyroxine and free triiodothyronine. Clin. Chem. 2010, 56:912-920.
110. Steele B.W., Wang E., Klee G.G., Thienpont L.M., Soldin S.J., Sokoll L.J., et al. Analytic bias of thyroid function tests: analysis of a College of American Pathologists Fresh Frozen Serum Pool by 3900 clinical laboratories. Arch. Pathol. Lab. Med. 2005, 129:310-317.
111. International Federation of Clinical C, Laboratory Medicine Ifcc ISDWGfSoTFTWGS, Thienpont L.M., Beastall G., Christofides N.D., Faix J.D., et al. Proposal of a Candidate International Conventional Reference Measurement Procedure for free thyroxine in serum. Clin. Chem. Lab. Med. 2007, 45:934-936.
112. Thienpont L.M., Beastall G., Christofides N.D., Faix J.D., Ieiri T., Miller W.G., et al. Measurement of free thyroxine in laboratory medicine-proposal of measurand definition. Clin. Chem. Lab. Med. 2007, 45:563-564.
113. Van Houcke S.K., Van Uytfanghe K., Shimizu E., Tani W., Umemoto M., Thienpont L.M., et al. IFCC international conventional reference procedure for the measurement of free thyroxine in serum: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group for standardization of thyroid function tests (WG-STFT) (1). Clin. Chem. Lab. Med. 2011, 49:1275-1281.
114. de Jong F.J., Peeters R.P., den Heijer T., van der Deure W.M., Hofman A., Uitterlinden A.G., et al. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J. Clin. Endocrinol. Metab. 2007, 92:636-640.
115. Peeters R.P., van Toor H., Klootwijk W., de Rijke Y.B., Kuiper G.G., Uitterlinden A.G., Visser T.J. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J. Clin. Endocrinol. Metab. 2003, 88:2880-2888.
116. Wehmann R.E., Nisula B.C. Radioimmunoassay of human thyrotropin: analytical and clinical developments. Crit. Rev. Clin. Lab. Sci. 1984, 20:243-283.